LOXL2 and cervical cancer: By ordering the 176 core-set cervical cancer samples by LOXL2 expression, we found that the somatic alteration density was high in the low-LOXL2 cluster when considering the top 50 (P = 4.24585E-05) (Figure 3D), top 1-10 (P = 3.40597E-05), top 21-30 (P = 0.048011) (Supplementary Figure 3B, and Supplementary Table 6) mutation genes in the dataset.